Cargando…
Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel human coronavirus that causes coronavirus disease 2019 (COVID-19), was first discovered in December 2019 as the cause of an outbreak of pneumonia in the city of Wuhan, Hubei province, China. The clinical presentation of COVID-19...
Autores principales: | Zhen, Wei, Manji, Ryhana, Smith, Elizabeth, Berry, Gregory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383517/ https://www.ncbi.nlm.nih.gov/pubmed/32341143 http://dx.doi.org/10.1128/JCM.00743-20 |
Ejemplares similares
-
Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2
por: Zhen, Wei, et al.
Publicado: (2020) -
Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection
por: Smith, Elizabeth, et al.
Publicado: (2020) -
Multicenter Evaluation of the BioFire Respiratory Panel 2.1 (RP2.1) for Detection of SARS-CoV-2 in Nasopharyngeal Swab Samples
por: Berry, Gregory J., et al.
Publicado: (2022) -
Multicenter Clinical Evaluation of the Luminex Aries Flu A/B & RSV Assay for Pediatric and Adult Respiratory Tract Specimens
por: Juretschko, Stefan, et al.
Publicado: (2017) -
Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens
por: Hogan, Catherine A., et al.
Publicado: (2020)